Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Drug Fights GLP-1 Muscle Loss; Unapproved Retatrutide Prescriptions; Protein Swap

Drug Fights GLP-1 Muscle Loss; Unapproved Retatrutide Prescriptions; Protein Swap
ShareXFacebook

(MedPage Today) -- Investigational apitegromab -- a selective myostatin activation inhibitor -- effectively preserved lean mass when combined with tirzepatide (Zepbound) in a randomized phase II trial, suggesting it could help fight "Ozempic...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement